Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Randomized Double-Blind Study to Compare the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD)

NCT00911534 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT00911534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00911534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Randomized Double-Blind Study to Compare the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD)
Lead sponsor
Eisai Inc.
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2009
Completion date
October 31, 2009
Enrollment
305 (actual)
Sites
98

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic gastroesophageal reflux disease (sgerd)